(Albany, US) DelveInsight launched a new report on Critical Limb Ischemia – Epidemiology Forecast to 2030
DelveInsight’s ‘Critical Limb Ischemia – Epidemiology Forecast to 2030‘ report delivers an in-depth understanding of the disease, historical and forecasted Critical Limb Ischemia epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Some of the key facts of the report
” According to Delveinsight, males are affected more as compared to females, in case of Critical Limb Ischemia.”
Critical Limb Ischemia (CLI) is a severe obstruction of the arteries which markedly reduces blood flow to the extremities (hands, feet, and legs) and has progressed to the point of severe pain and even skin ulcers or sores. The pain caused by CLI can wake up an individual at night. This pain, also called “rest pain”, is often in the leg and can be relieved temporarily by hanging the leg over the bed or getting up to walk around.
CLI is a very severe condition of peripheral artery disease (PAD) and needs comprehensive treatment by a vascular surgeon or vascular specialist. It is the advanced stage of peripheral artery disease (PAD), which results from a progressive thickening of an artery’s lining (caused by a buildup of plaque). This buildup of plaque, also known as atherosclerosis, narrows or blocks blood flow, reducing circulation of blood to the legs, feet, or hands.
The risk factors for critical limb ischemia include Age (Men over 60 and women after menopause),
Smoking, Diabetes, Overweight or obesity, High cholesterol, High blood pressure.
Request for sample pages : https://www.delveinsight.com/sample-request/critical-limb-ischemia-epidemiology-forecast
Scope of the Report
KOL- Views
We interview, KOLs and SME’s opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.
Key Questions Answered
Reasons to buy
Key Assessments
Related Reports:
Critical Limb Ischemia – Pipeline Insights, 2020
The Critical Limb Ischemia report provides an overview of therapeutic pipeline activity and therapeutic assessment of the products by development stage, product type, route of administration, molecule type, and MOA type for Critical Limb Ischemia across the complete product development cycle, including all clinical and nonclinical stages.
Critical Limb Ischemia – Market Insights, Epidemiology, and Market Forecast-2030
The Critical Limb Ischemia market report provides current treatment practices, emerging drugs, Critical Limb Ischemia market share of the individual therapies, current and forecasted Critical Limb Ischemia market Size from 2017 to 2030 segmented by seven major markets.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/